Eiger BioPharmaceuticals, Inc. 4 SEC Filings

Filed On	Filing
02 Nov 2023	Form 4: Kayne Richard A, 10% owner Bought 154,841 shares ($37.9K) · Bought 100,000 shares ($28K) · Bought 23,398 shares ($6.97K)
02 Nov 2023	Form 4: Kawas Leen, 10% owner Bought 24,332 shares ($6.37K)
05 Sep 2023	Form 4: Choong Ingrid, Chief Business Officer Granted 54,000 Stock Option (Right to Buy)
06 Jul 2023	Form 4: Apelian David, Director Granted 750,000 Stock Option (Right to Buy)
02 May 2023	Form 4: Vollins James, General Counsel Granted 120,000 Stock Option (Right to Buy)
21 Mar 2023	Form 4: Mayer Eldon C. Iii, Ex VP & Chief Commerc. Officer Sold 4,395 shares ($4.7K)
03 Mar 2023	Form 4: Sachdev Amit, Director Granted 28,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Loh Evan, Director Granted 28,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Murray Christine, Director Granted 28,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Glenn Jeffrey S, Director Granted 28,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Sablich Kim, Director Granted 28,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Kelly-Croswell Lisa, Director Granted 28,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Mayer Eldon C. Iii, Ex VP & Chief Commerc. Officer Granted 98,000 Stock Option (Right to Buy)
03 Mar 2023	Form 4: Dietz Thomas John, Director Granted 40,000 Stock Option (Right to Buy)
02 Feb 2023	Form 4: Apelian David, Director Granted 170,000 Stock Option (Right to Buy)
30 Jan 2023	Form 4: Mayer Eldon C. Iii, Ex VP & Chief Commerc. Officer Granted 31,500 Stock Option (Right to Buy)
30 Jan 2023	Form 4: Atkisson Erik, GC & Chief Compliance Officer Granted 26,750 Stock Option (Right to Buy)
25 Jan 2023	Form 4: Dietz Thomas John, Director Bought 50,000 shares ($71.6K)
03 Jan 2023	Form 4: Murray Christine, Director Sold 5,000 shares ($6.1K)
27 Dec 2022	Form 4: Dietz Thomas John, Director Sold 22,500 shares ($26.3K)

Comments